Literature DB >> 14964442

Effects of androgen replacement on metabolism and physical performances in male hypogonadism.

M Zitzmann1, E Nieschlag.   

Abstract

Hypogonadism in men is associated with decreased physical performance. This phenomenon depends on significantly measurable adverse traits in body composition, namely increased body fat content and reduced muscle mass. Physical abilities in hypogonadal men are further hampered by lower oxygen supply due to decreased hemoglobin concentrations and by poor glucose utilization. In addition, dysthymia and lack of necessary aggressiveness contribute to further deterioration of physical features. T substitution can improve lipid and insulin metabolism, resuiting in changes of body composition, such as decreasing fat depots. Growth of muscle fibers can also be observed. Stabilization of the musculo-skeletal system by increased bone density will further contribute to increased physical fitness, reflected by increased strength and endurance. Treatment outcome is strongly influenced by age and training. The issues reviewed strongly support T treatment of hypogonadal men accompanied by regular monitoring.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14964442     DOI: 10.1007/BF03345240

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  70 in total

1.  Effect of testosterone treatment on bone mineral density in men over 65 years of age.

Authors:  P J Snyder; H Peachey; P Hannoush; J A Berlin; L Loh; J H Holmes; A Dlewati; J Staley; J Santanna; S C Kapoor; M F Attie; J G Haddad; B L Strom
Journal:  J Clin Endocrinol Metab       Date:  1999-06       Impact factor: 5.958

2.  Testosterone and regional fat distribution.

Authors:  P Mårin
Journal:  Obes Res       Date:  1995-11

3.  Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study.

Authors:  R K Stellato; H A Feldman; O Hamdy; E S Horton; J B McKinlay
Journal:  Diabetes Care       Date:  2000-04       Impact factor: 19.112

4.  Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.

Authors:  A Vermeulen; J M Kaufman; V A Giagulli
Journal:  J Clin Endocrinol Metab       Date:  1996-05       Impact factor: 5.958

5.  Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II study.

Authors:  Sigrid von Eckardstein; Eberhard Nieschlag
Journal:  J Androl       Date:  2002 May-Jun

Review 6.  Testosterone, body composition and aging.

Authors:  A Vermeulen; S Goemaere; J M Kaufman
Journal:  J Endocrinol Invest       Date:  1999       Impact factor: 4.256

7.  Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial.

Authors:  H G Pope; E M Kouri; J I Hudson
Journal:  Arch Gen Psychiatry       Date:  2000-02

8.  Decreased bone density in ambulatory patients with duchenne muscular dystrophy.

Authors:  Luis F Aparicio; Marguerite Jurkovic; James DeLullo
Journal:  J Pediatr Orthop       Date:  2002 Mar-Apr       Impact factor: 2.324

9.  The relation between bone density, free androgen index, and estradiol in men 60 to 70 years old.

Authors:  F Scopacasa; M Horowitz; J M Wishart; H A Morris; B E Chatterton; A G Need
Journal:  Bone       Date:  2000-07       Impact factor: 4.398

10.  Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM.

Authors:  R Malmström; M R Taskinen; S L Karonen; H Yki-Järvinen
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

View more
  3 in total

Review 1.  Andrological aspects of physical exercise and sport medicine.

Authors:  Luigi Di Luigi; Francesco Romanelli; Paolo Sgrò; Andrea Lenzi
Journal:  Endocrine       Date:  2012-03-20       Impact factor: 3.633

2.  Urinary and serum hormones profiles after testosterone enanthate administration in male hypogonadism: concerns on the detection of doping with testosterone in treated hypogonadal athletes.

Authors:  L Di Luigi; P Sgrò; F Romanelli; M Mazzarino; F Donati; M C Braganò; S Bianchini; V Fierro; M Casasco; F Botrè; A Lenzi
Journal:  J Endocrinol Invest       Date:  2009-03-24       Impact factor: 4.256

Review 3.  Sport, doping and male fertility.

Authors:  Andrea Sansone; Massimiliano Sansone; Diana Vaamonde; Paolo Sgrò; Ciro Salzano; Francesco Romanelli; Andrea Lenzi; Luigi Di Luigi
Journal:  Reprod Biol Endocrinol       Date:  2018-11-12       Impact factor: 5.211

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.